Long term administration of low doses of mycotoxins in poultry. 2. Residues of ochratoxin A and aflatoxins in broilers and laying hens after combined administration of ochratoxin A and aflatoxin B1

1988 ◽  
Vol 5 (3) ◽  
pp. 309-314 ◽  
Author(s):  
C. Micco ◽  
M. Miraglia ◽  
L. Benelli ◽  
R. Onori ◽  
A. Ioppolo ◽  
...  
1988 ◽  
Vol 5 (3) ◽  
pp. 303-308 ◽  
Author(s):  
C. Micco ◽  
M. Miraglia ◽  
R. Onori ◽  
C. Brera ◽  
Al. Mantovani ◽  
...  

1987 ◽  
Vol 66 (1) ◽  
pp. 47-50 ◽  
Author(s):  
C. MICCO ◽  
M. MIRAGLIA ◽  
R. ONORI ◽  
A. IOPPOLO ◽  
A. MANTOVANI

1989 ◽  
Vol 68 (6) ◽  
pp. 744-748 ◽  
Author(s):  
D.B. PRELUSKY ◽  
R.M.G. HAMILTON ◽  
H.L. TRENHOLM

1977 ◽  
Author(s):  
C. Raby ◽  
H. Bertrand

Thirty five patients with severe evolutive arteriopathy were selected since following the advent of their first accident and although they received classical treatment they experienced at least one or sometimes several relapses of thrombosis. These patients were subjected to discontinuous subcutaneous ambulatory heparin treatment. This treatment consisted of two daily injections of 5,000–10,000 IU calcium-heparin (Calciparine) depending on each patient’s weight, during 30 days every three months. A backward survey of nine years for the patients first treated and of over two years for those most recently examined indicated that such patients never underwent recurrence of the disease and were considerably functionally improved. Experimentally in the animal and after subcutaneous injection of low doses of using 35s labeled heparin we have shown that heparin remains bound both on arterial and venous endothelium at least 15 hours after all anticoagulant activity has disappeared from circulating blood. As a rule and depending on individuals the relationship between the dose and the persistence of heparin bound on the wall is much more constant than that existing between the dose and the duration of the anticoagulant effect. Low doses (100-150 IU/kg in man) repeated twice a day will suffice to ensure the persistence of an endothelial coating. This coating could account for the excellent clinical results obtained.


1993 ◽  
Vol 73 (4) ◽  
pp. 189-191 ◽  
Author(s):  
Juan J. Muñoz ◽  
Cristina Roca ◽  
José L. Santos ◽  
Miguel Arroyo ◽  
Rafael E. Salamanca

2011 ◽  
Vol 92 (7) ◽  
pp. 1540-1544 ◽  
Author(s):  
Zahoor Ul Hassan ◽  
Muhammad Z Khan ◽  
Ahrar Khan ◽  
Ijaz Javed ◽  
Zahid Hussain

2013 ◽  
Vol 10 (2) ◽  
pp. 9-13 ◽  
Author(s):  
O N Tkacheva ◽  
N K Runikhina ◽  
N V Sharashkina

Effective and safe diuretic torasemide has additional effects of renin-angiotensin-aldosterone system blockage. Torasemide can be used as monotherapy or combined with other antihypertensives. In low doses torasemide produces pronounced antihypertensive effect without augmentation of excretion of potassium and water with urine. Long-term administration of torasemide was not associated with significant effects on lipid, purine, carbohydrate, or electrolyte metabolism parameters. Torasemide particularly effective in postmenopausal women, as these women are more likely formed low-renin hypertension. Therefore, torasemide can be used more widely in modern clinical practice.


2003 ◽  
Vol 20 (7) ◽  
pp. 648-653 ◽  
Author(s):  
C. A. Fernandes Oliveira ◽  
J. Fontes Rosmaninho ◽  
A. L. Castro ◽  
P. Butkeraitis ◽  
T. Alves Reis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document